Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based

Annalisa Blasetti1, Concetta Di Giulio, Anna Maria Tocco

  • 1Department of Pediatrics, University of Chieti, Via dei Vestini 5, Chieti, Italy. ablasetti@tiscalinet.it

Pediatric Diabetes
|August 21, 2010
PubMed

Insights

Severe hypoglycemia (SH) in type 1 diabetes mellitus (T1DM) is linked to longer diabetes duration and specific insulin ratios. Patient education is key for SH prevention in children and adolescents.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Management

Background:

  • Hypoglycemia is a significant challenge in type 1 diabetes mellitus (T1DM) management.
  • Intensive T1DM treatment increases severe hypoglycemia (SH) risk.
  • Understanding SH incidence and predictors in pediatric populations is crucial.

Purpose of the Study:

  • To determine the incidence of severe hypoglycemia (SH) in children and adolescents with T1DM.
  • To identify variables associated with SH in this demographic.
  • To inform strategies for improved T1DM care and safety.

Main Methods:

  • Prospective study over 7.5 years involving 195 pediatric T1DM patients.
  • SH defined as blood glucose <50 mg/dL with altered consciousness.
  • Data collected on HbA1c, insulin dose, regimen, duration, and age at onset.

Main Results:

  • Overall SH incidence was 9.4 episodes per 100 patient-years.
  • Predictors of SH included diabetes duration >10 years and basal/bolus insulin ratio >0.8.
  • No significant association found between SH and HbA1c, daily insulin needs, or insulin regimen.

Conclusions:

  • A relatively low incidence of SH was observed in this pediatric T1DM cohort.
  • SH was primarily linked to diabetes management rather than glycemic control (HbA1c) or insulin therapy type.
  • Patient and family education is emphasized as the primary strategy for SH prevention.
Abstract

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...